PDT Partners’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-158,384
Closed -$3.68M 745
2024
Q2
$3.68M Hold
158,384
0.35% 72
2024
Q1
$3.25M Buy
158,384
+125,484
+381% +$2.36M 0.31% 98
2023
Q4
$706K Buy
+32,900
New +$652K 0.08% 349
2022
Q4
Sell
-30,588
Closed -$939K 697
2022
Q3
$939K Sell
30,588
-5,753
-16% -$187K 0.14% 241
2022
Q2
$1.07M Buy
36,341
+18,491
+104% +$484K 0.09% 372
2022
Q1
$574K Buy
+17,850
New +$614K 0.05% 538
2021
Q4
Sell
-15,200
Closed -$767K 902
2021
Q3
$767K Buy
15,200
+10,466
+221% +$590K 0.06% 397
2021
Q2
$371K Sell
4,734
-17,531
-79% -$1.08M 0.02% 574
2021
Q1
$1.27M Buy
22,265
+4,552
+26% +$305K 0.09% 326
2020
Q4
$1.48M Sell
17,713
-54,224
-75% -$3.28M 0.1% 271
2020
Q3
$2.58M Buy
71,937
+13,537
+23% +$408K 0.17% 191
2020
Q2
$1.41M Sell
58,400
-18,300
-24% -$430K 0.1% 242
2020
Q1
$1.34M Buy
76,700
+38,797
+102% +$809K 0.11% 194
2019
Q4
$660K Sell
37,903
-1,409
-4% -$23.5K 0.04% 361
2019
Q3
$602K Buy
39,312
+28,092
+250% +$537K 0.04% 325
2019
Q2
$233K Buy
+11,220
New +$251K 0.01% 357

Other funds holding DNLI